APA (7th ed.) Citation

DI, B., & TEG, E. (2020). Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy. Allergy and asthma proceedings, 41(2), 108. https://doi.org/10.2500/aap.2020.41.200001

Chicago Style (17th ed.) Citation

DI, Bernstein, and Epstein TEG. "Safety of Allergen Immunotherapy in North America from 2008-2017: Lessons Learned from the ACAAI/AAAAI National Surveillance Study of Adverse Reactions to Allergen Immunotherapy." Allergy and Asthma Proceedings 41, no. 2 (2020): 108. https://doi.org/10.2500/aap.2020.41.200001.

MLA (9th ed.) Citation

DI, Bernstein, and Epstein TEG. "Safety of Allergen Immunotherapy in North America from 2008-2017: Lessons Learned from the ACAAI/AAAAI National Surveillance Study of Adverse Reactions to Allergen Immunotherapy." Allergy and Asthma Proceedings, vol. 41, no. 2, 2020, p. 108, https://doi.org/10.2500/aap.2020.41.200001.